%0 Journal Article
%T Interaction of Avelox with Bovine Serum Albumin and Effect of the Coexistent Drugs on the Reaction
%A Baosheng Liu
%A Chao Yang
%A Xiaona Yan
%A Jing Wang
%A Yunkai Lv
%J International Journal of Analytical Chemistry
%D 2012
%I Hindawi Publishing Corporation
%R 10.1155/2012/408057
%X The interaction between Avelox and bovine serum albumin (BSA) was investigated at different temperatures by fluorescence spectroscopy. Results showed that Avelox could quench the intrinsic fluorescence of BSA strongly, and the quenching mechanism was a static quenching process with F£¿rester spectroscopy energy transfer. The electrostatic force played an important role on the conjugation reaction between BSA and Avelox. The order of magnitude of binding constants ( ) was 104, and the number of binding site ( ) in the binary system was approximately equal to 1. The binding distance ( ) was less than 3£¿nm and the primary binding site for Avelox was located in subdomain IIA of BSA. Synchronous fluorescence spectra clearly revealed that the microenvironment of amino acid residues and the conformation of BSA were changed during the binding reaction. In addition, the effect of some antibiotics on the binding constant of Avelox with BSA was also studied. 1. Introduction Most drugs are able to bind to plasma protein when they entrance in blood plasma system of organism, and serum albumin is the most abundant protein in blood plasma and serves as a depot protein and transport protein for numerous endogenous and exogenous compounds [1]. Generally speaking, drugs could bind with serum albumin mostly through the formation of noncovalent complexes reversibly. The drug-protein complex can be regarded as a form of drug in the biology temporary storage, it can effectively avoid drug elimination from metabolism so quickly that it can maintain the total concentration and effective concentrations of blood medicine in plasma. In addition, binding of drugs to plasma proteins controls their free, active concentrations and provides a reservoir for a longer action, the binding of drugs is responsible for the protective role of albumin. Therefore, interaction of a drug with, and competition for, the binding sites on plasma proteins might strongly affect its distribution, elimination, as well as its pharmacodynamics and toxic properties [2]. Competition between two drugs for their binding to plasma protein can strongly affect the drug disposition of both drugs, with possible serious physiological consequences. Binding parameters are indeed fundamental factors in determining the overall pharmacological activity of a drug, and in this context the determination of the binding parameters of drugs to albumin has become essential to understand their pharmacokinetic, pharmacodynamic, and toxicological profile. Avelox is a new generation of fluoroquinolone antibacterial agents, which is
%U http://www.hindawi.com/journals/ijac/2012/408057/